Metabolomics:Open Access

7^th International Conference and Expo on Metabolomics

November 14-16, 2016 Orlando, Florida, USA

Keynote

• Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly (ADP-ribose) polymerase (PARP) inhibitors

  David A Boothman

  PDF HTML

• Metabolomics adds function to precision diagnosis

  C Thomas Caskey

  PDF HTML

• Omics data strategy, precision medicine and modern biotechnology revolution

  Dongliang Ge

  PDF HTML

• Clinical metabolomics: Creating patient and population centric analytical tools for drug development

  Vladimir Tolstikov

  PDF HTML

• Clinical metabolomics: Creating patient and population centric analytical tools for drug development

  Vladimir Tolstikov

  PDF HTML